Ventas Future Growth
Future criteria checks 3/6
Ventas is forecast to grow earnings and revenue by 54.7% and 7.4% per annum respectively. EPS is expected to grow by 54.9% per annum. Return on equity is forecast to be 4.3% in 3 years.
Key information
54.7%
Earnings growth rate
54.9%
EPS growth rate
Health Care REITs earnings growth | 24.4% |
Revenue growth rate | 7.4% |
Future return on equity | 4.3% |
Analyst coverage | Good |
Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 5,624 | 232 | 1,015 | 1,726 | 5 |
12/31/2025 | 5,242 | 130 | 936 | 1,549 | 9 |
12/31/2024 | 4,895 | 47 | 827 | 1,410 | 5 |
9/30/2024 | 4,797 | -67 | 942 | 1,235 | N/A |
6/30/2024 | 4,706 | -157 | 882 | 1,168 | N/A |
3/31/2024 | 4,615 | -73 | 878 | 1,144 | N/A |
12/31/2023 | 4,500 | -41 | 860 | 1,120 | N/A |
9/30/2023 | 4,359 | 5 | 880 | 1,108 | N/A |
6/30/2023 | 4,256 | 77 | 895 | 1,122 | N/A |
3/31/2023 | 4,173 | -69 | 859 | 1,088 | N/A |
12/31/2022 | 4,116 | -47 | 898 | 1,120 | N/A |
9/30/2022 | 4,079 | -43 | 898 | 1,119 | N/A |
6/30/2022 | 4,019 | 16 | 848 | 1,050 | N/A |
3/31/2022 | 3,921 | 145 | 871 | 1,063 | N/A |
12/31/2021 | 3,818 | 49 | 841 | 1,026 | N/A |
9/30/2021 | 3,760 | 200 | 883 | 1,056 | N/A |
6/30/2021 | 3,701 | 152 | 1,090 | 1,259 | N/A |
3/31/2021 | 3,703 | -91 | 1,222 | 1,373 | N/A |
12/31/2020 | 3,790 | 439 | 1,302 | 1,450 | N/A |
9/30/2020 | 3,847 | 340 | 1,357 | 1,509 | N/A |
6/30/2020 | 3,911 | 413 | 1,277 | 1,429 | N/A |
3/31/2020 | 3,925 | 780 | 1,255 | 1,416 | N/A |
12/31/2019 | 3,859 | 433 | 1,281 | 1,438 | N/A |
9/30/2019 | 3,781 | 484 | 1,289 | 1,447 | N/A |
6/30/2019 | 3,720 | 501 | 1,252 | 1,400 | N/A |
3/31/2019 | 3,714 | 457 | 1,276 | 1,410 | N/A |
12/31/2018 | 3,702 | 409 | 1,250 | 1,381 | N/A |
9/30/2018 | 3,668 | 740 | 1,242 | 1,364 | N/A |
6/30/2018 | 3,646 | 1,252 | N/A | 1,416 | N/A |
3/31/2018 | 3,607 | 1,237 | N/A | 1,391 | N/A |
12/31/2017 | 3,568 | 1,357 | N/A | 1,429 | N/A |
9/30/2017 | 3,560 | 1,172 | N/A | 1,448 | N/A |
6/30/2017 | 3,527 | 707 | N/A | 1,435 | N/A |
3/31/2017 | 3,481 | 699 | N/A | 1,441 | N/A |
12/31/2016 | 3,447 | 650 | N/A | 1,355 | N/A |
9/30/2016 | 3,410 | 569 | N/A | 1,376 | N/A |
6/30/2016 | 3,369 | 465 | N/A | 1,335 | N/A |
3/31/2016 | 3,331 | 453 | N/A | 1,325 | N/A |
12/31/2015 | 3,284 | 407 | N/A | 1,399 | N/A |
9/30/2015 | 3,171 | 366 | N/A | 1,357 | N/A |
6/30/2015 | 3,049 | 412 | N/A | 1,377 | N/A |
3/31/2015 | 2,836 | 361 | N/A | 1,315 | N/A |
12/31/2014 | 2,772 | 376 | N/A | 1,255 | N/A |
9/30/2014 | 2,776 | 398 | N/A | 1,279 | N/A |
6/30/2014 | 2,783 | 435 | N/A | 1,283 | N/A |
3/31/2014 | 2,868 | 487 | N/A | 1,249 | N/A |
12/31/2013 | 2,514 | 374 | N/A | 1,195 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: V1TA34 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (10.4%).
Earnings vs Market: V1TA34 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: V1TA34 is expected to become profitable in the next 3 years.
Revenue vs Market: V1TA34's revenue (7.4% per year) is forecast to grow slower than the BR market (7.4% per year).
High Growth Revenue: V1TA34's revenue (7.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: V1TA34's Return on Equity is forecast to be low in 3 years time (4.3%).